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Abstract
Background: Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive disease. For patients with
operable CTEPH, there is a clear recommendation for surgical removal of persistent thrombi by pulmonary
endarterectomy (PEA). However, without the presence of PH, therapeutic management of chronic thromboembolic
disease (CTED) is challenging - especially in highly trained subjects exceeding predicted values of maximal exercise
capacity.
Case presentation: A 43-year-old male athlete reported with progressive exercise limitation since 8 months. Six months
earlier, pulmonary embolism had occurred, and was treated since with oral anticoagulation. A pulmonary ventilation/
perfusion scan showed severe ventilation/perfusion mismatch: chest CT and pulmonary angiography revealed bilateral
wall-adherent thrombotic material, but pulmonary hemodynamics were completely normal. His peak oxygen uptake
exceeded predicted values, however exercise ventilatory efficiency was abnormal, compared to a matching athlete. After
thoroughly discussing therapeutic options with the patient, he successfully underwent pulmonary endarterectomy at an
expert center. Five and twelve months after surgery, his maximal exercise capacity and ventilatory efficiency profoundly
improved beyond preoperative values, and his subjective exercise tolerance had returned to normal.
Conclusions: Significant CTED may be present without relevant pathologic changes in pulmonary hemodynamics at rest.
Reaching normal values of maximal exercise capacity does not exclude pulmonary vascular disease in highly trained
subjects. More data are needed to evaluate the risk-/benefit ratio of PEA in patients with CTED and normal pulmonary
hemodynamics. A thorough discussion with the patient as well as shared decision making regarding therapy are
mandatory. Cardiopulmonary exercise testing may add important clinical information in the non-invasive diagnostic
evaluation at baseline and during follow-up.
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Background
Chronic thromboembolic pulmonary hypertension
(CTEPH) is a progressive disease caused by wall-
adherent, fibrotic thromboembolic material in the
precapillary pulmonary circulation, despite oral antic-
oagulation. For patients with operable CTEPH, there
is a clear recommendation for surgical removal of
persistent thrombi by pulmonary endarterectomy
(PEA) as a curative approach in specialized centers
[1, 2]. However, without the presence of PH, thera-
peutic management of chronic thromboembolic dis-
ease (CTED) is challenging [3]. Currently, there is
only rare evidence on therapeutic strategies of CTED
and normal hemodynamics. In selected cases such as
in athletes, reduced exercise tolerance and dyspnea
may be related to the extent of persistent pulmonary
perfusion defects and dead space ventilation, despite
exceeding predicted values of maximal exercise cap-
acity and normal pulmonary hemodynamics.
* Correspondence: stephan.rosenkranz@uk-koeln.de
1Klinik III für Innere Medizin, Herzzentrum der Universität zu Köln, Kerpener
Str. 62, 50937 Köln, Germany
Full list of author information is available at the end of the article
© 2016 Dumitrescu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Dumitrescu et al. BMC Pulmonary Medicine  (2016) 16:21 
DOI 10.1186/s12890-016-0180-x
Case Presentation
We report the case of a 43-year-old male athlete (190 cm,
82 kg) who presented with progressive dyspnea and sub-
jective exercise limitation in the prior 8 months. He was
able to cycle a distance of 50 kilometers per day and
reported a continuously decreased ability to sustain this
effort. Other daily activities were not affected. He had
suffered from pulmonary embolism 6 months prior to
presentation, and had permanently been on therapeutic
oral anticoagulation since this time point. He did not re-
port any other known diseases.
Physical examination did not reveal any relevant find-
ings. Pulmonary function testing did not show any re-
strictive or obstructive limitation, with normal diffusion
capacity. Echocardiography showed normal values, except
a slightly enlarged right ventricle (basal diameter 42 mm)
and a slightly enlarged right atrium (area 19.8 cm2). No
tricuspid regurgitation could be detected.
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Fig. 1 Functional assessment and imaging of chronic thromboembolic material in the pulmonary circulation. a VE/VCO2 ratio during exercise.
Lower values indicate better ventilatory efficiency. Compared to a matching athlete (male, 46 y, 177 cm, 70 kg), impaired ventilatory efficiency is
visible, reflecting ventilation/perfusion mismatch. b Ventilation-/perfusion (V/Q) scan showing large defects in the right upper lobe and in the left
lower lobe. c V/Q scan 12 months after PEA, showing a substantial reduction of previously documented perfusion defects. d Surgical specimen.
Successful bilateral pulmonary endarterectomy of wall-adherent thrombotic material with advanced fibrotic remodelling
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The patient’s maximal exercise performance during
cardiopulmonary exercise testing (CPET) was excellent,
compared to his predicted values. He exercised on a
cycle ergometer with a ramp protocol of 25 Watts per
minute, and achieved 115 % of his predicted peak oxy-
gen uptake. Ventilatory efficiency was normal, relative to
predicted values for an untrained, adult population [4].
However, compared to an athlete with a matching exer-
cise capacity, his ventilatory efficiency during exercise
was reduced, expressed by an elevated ratio of minute
ventilation to CO2 output (VE/VCO2), indicating a ven-
tilation-/perfusion mismatch during exercise (Fig. 1a). A
pulmonary ventilation/perfusion scan revealed large
bilateral perfusion defects (Fig. 1b), which could be con-
firmed by CT scan. Surprisingly, the patient’s pulmonary
hemodynamics were completely normal. Mean pulmon-
ary arterial pressure was 18 mmHg, with a pulmonary
arterial occlusion (wedge) pressure of 7 mmHg, a cardiac
index of 3.85 L/Min/m2 and a pulmonary vascular resist-
ance of 1.35 wood units. Additionally, invasive exercise
hemodynamics were obtained at a workload of 200
Watts. Mean pulmonary arterial pressure increased up
to 43 mmHg, however with a constant pulmonary ar-
terial occlusion pressure and a substantial increase in
cardiac output, so that pulmonary vascular resistance
remained slightly unchanged at 1.56 wood units.
Current guidelines do not recommend the use of the
term ‘exercise induced PH’ [1], as there is not sufficient
evidence to support the definition. A current publica-
tion suggests to define a pathological exercise
hemodynamic response as an increase of mean PAP
above 30 mmHg, combined with a cardiac output of
less than 10 L/Min, or with a PVR of less than 3 Wood
units (240 dyn x sec x cm-5) [5]. However, according to
this definition, even exercise hemodynamics were
normal in this case.
For this situation, currently no evidence-based thera-
peutic recommendations are available. One single-center
study retrospectively analyzed all patients with CTED and
normal hemodynamics who had undergone surgery [3].
Almost all patients improved in functional class, however
changes in six-minute walking distance (6MWD), were
heterogeneous. Although none of the patients died, major
complications occurred in 40 % of the cases.
In the present case, therapeutic options were thor-
oughly discussed with the patient. He expressed a high
degree of suffering. Considering the progressive nature
of the disease, and in consensus with the patient’s re-
quest, he was referred to an experienced center for PEA.
Pulmonary angiography confirmed surgical accessibility
of the thromboembolic material. The patient successfully
underwent surgery 3 months after initial presentation
(surgical specimen, Fig. 1d). Lifelong oral anticoagulation
was recommended. An inferior vena cava filter (IVC)
was not inserted. There were no complications during
the PEA procedure or during the post-operative phase.
The patient was discharged from hospital 10 days after
the procedure.
Two months after PEA, the patient was re-evaluated
by echocardiography and CPET. At this time point, the
patient did not feel any subjective improvement. Right
ventricular dimensions were unchanged, however tricus-
pid annular plane systolic excursion (TAPSE) was re-
duced to 16 mm – compared to 22 mm before PEA.
Peak oxygen uptake was reduced to 94 % of predicted
values, however ventilatory efficiency had improved,
reflected by a lower VE/VCO2 ratio (Fig. 2a).
However, five months after PEA, a significant treatment
success could be documented. The patient reported to feel
better, and peak oxygen uptake significantly improved to
4.0 L/Min (136 % of predicted values). Ventilatory
efficiency was not normalized but further improved,
Fig. 2 Non-invasive serial measurements in a 43-year old, athletic patient with CTED and normal pulmonary hemodynamics. a CPET results.
Constant improvement of ventilatory efficiency after surgery, reflected by decreasing VE/VCO2 ratio and increasing peak PETCO2 values. Delayed
improvement of peak VO2. b Results of other non-invasive diagnostic tools established for serial follow-up in PH. Delayed improvement of
ventricular function. Constant results of 6-minute walking distance
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documented by a lower VE/VCO2 ratio compared to all
previous tests (Fig. 2a).
One year after PEA; a follow-up ventilation-/perfusion
scan showed minor residual defects (Fig. 1c). In accordance
with these findings, CPET showed a sustained improvement
of peak oxygen uptake and of ventilatory efficiency,
reflected by a decreased VE/VCO2 ratio and substantially
higher peak PETCO2 values during exercise (Fig. 2a). TAPSE
and NTpro-BNP levels had returned to normal (Fig. 2b).
Follow-up measurements in patients with CTED and
normal pulmonary hemodynamics are challenging. Cur-
rently, there is only one published case report in the litera-
ture [6]. Here, therapeutic effects were documented by
CPET during serial follow-up visits. A substantial improve-
ment in maximal exercise performance and in ventilatory
efficiency could be demonstrated six months after surgery.
At present, there are no data showing early effects
after PEA in patients with normal hemodynamics. How-
ever, insights gained from CTEPH suggest that restor-
ation of right and left ventricular function may be
delayed [7, 8].
Conclusion
This case remarkably demonstrates that significant
chronic thromboembolic disease may be present without
relevant pathologic changes in pulmonary hemodynamics
at rest. Cardiopulmonary limitation may be masked by a
high level of physical fitness. Thus, reaching normal values
of maximal exercise capacity does not exclude pulmonary
vascular disease in highly trained subjects. CPET may add
clinical information on the degree of pulmonary ventila-
tion-/perfusion mismatching during exercise.
Although pathophysiological considerations suggest a
beneficial treatment effect, more data are needed to evalu-
ate the risk-/benefit ratio of PEA in patients with CTED
and normal pulmonary hemodynamics. A thorough
discussion with the patient as well as shared decision mak-
ing regarding therapy are mandatory. Patients should only
be referred to PEA expert centers. Successful surgical re-
moval of chronic thromboembolic material may lead to
beneficial, sustained treatment effects even in patients
with normal pulmonary hemodynamics. However, the on-
set of these effects may be delayed. CPET may adequately
reflect the response to therapy over time.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images.
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